Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 64

Similar articles for PubMed (Select 22356892)

1.

Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy.

Lee TH, Szabo ST, Fowler JC, Mannelli P, Mangum OB, Beyer WF, Patkar A, Wetsel WC.

Drug Alcohol Depend. 2012 Jul 1;124(1-2):11-8. doi: 10.1016/j.drugalcdep.2012.01.021. Epub 2012 Feb 21. Review.

2.

Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.

Bubar MJ, Cunningham KA.

Prog Brain Res. 2008;172:319-46. doi: 10.1016/S0079-6123(08)00916-3. Review.

PMID:
18772040
3.

Reversal of long-term methamphetamine sensitization by combination of pergolide with ondansetron or ketanserin, but not mirtazapine.

Bhatia KS, Szabo ST, Fowler JC, Wetsel WC, Lee TH.

Behav Brain Res. 2011 Sep 30;223(1):227-32. doi: 10.1016/j.bbr.2011.04.045. Epub 2011 May 7.

4.

Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence.

Bubar MJ, Cunningham KA.

Curr Top Med Chem. 2006;6(18):1971-85. Review.

PMID:
17017968
5.

Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.

Broderick PA, Hope O, Okonji C, Rahni DN, Zhou Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):157-71.

PMID:
14687870
6.

Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.

Xi ZX, Gardner EL.

Curr Drug Abuse Rev. 2008 Nov;1(3):303-27. Review.

7.

Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review.

Lu L, Shepard JD, Hall FS, Shaham Y.

Neurosci Biobehav Rev. 2003 Aug;27(5):457-91. Review.

PMID:
14505687
8.

Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation.

Schoffelmeer AN, De Vries TJ, Wardeh G, van de Ven HW, Vanderschuren LJ.

J Neurosci. 2002 Apr 15;22(8):3269-76.

9.

Dopamine/serotonin releasers as medications for stimulant addictions.

Rothman RB, Blough BE, Baumann MH.

Prog Brain Res. 2008;172:385-406. doi: 10.1016/S0079-6123(08)00919-9. Review.

PMID:
18772043
10.

Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies.

Broderick PA, Olabisi OA, Rahni DN, Zhou Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 May;28(3):547-57.

PMID:
15093963
11.

Characterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuse.

Mason CW, Hassan HE, Kim KP, Cao J, Eddington ND, Newman AH, Voulalas PJ.

J Pharmacol Exp Ther. 2010 Jun;333(3):854-64. doi: 10.1124/jpet.109.165084. Epub 2010 Mar 12.

12.

The importance of the adenosine A(2A) receptor-dopamine D(2) receptor interaction in drug addiction.

Filip M, Zaniewska M, Frankowska M, Wydra K, Fuxe K.

Curr Med Chem. 2012;19(3):317-55. Review.

PMID:
22335511
13.

Dopamine receptor agonists, partial agonists and psychostimulant addiction.

Pulvirenti L, Koob GF.

Trends Pharmacol Sci. 1994 Oct;15(10):374-9. Review.

PMID:
7809953
14.
15.

ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.

Li Z, Ichikawa J, Huang M, Prus AJ, Dai J, Meltzer HY.

Psychopharmacology (Berl). 2005 Dec;183(2):144-53. Epub 2005 Nov 9.

PMID:
16220333
16.

Monoamine transporters and psychostimulant addiction.

Howell LL, Kimmel HL.

Biochem Pharmacol. 2008 Jan 1;75(1):196-217. Epub 2007 Aug 7. Review.

PMID:
17825265
17.

Conditioned and sensitized responses to stimulant drugs in humans.

Leyton M.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Nov 15;31(8):1601-13. Epub 2007 Aug 28. Review.

PMID:
17888557
18.

Pretreatment with serotonin 5-HT(3) receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats.

Szumlinski KK, Frys KA, Kalivas PW.

Psychopharmacology (Berl). 2003 Feb;165(4):329-36. Epub 2002 Nov 26.

PMID:
12451437
19.

Serotonergic involvement in methamphetamine-induced locomotor activity: a detailed pharmacological study.

Steed E, Jones CA, McCreary AC.

Behav Brain Res. 2011 Jun 20;220(1):9-19. doi: 10.1016/j.bbr.2011.01.026. Epub 2011 Jan 22.

PMID:
21262272
20.

Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice.

Ago Y, Nakamura S, Baba A, Matsuda T.

J Pharmacol Sci. 2008 Jan;106(1):15-21. Epub 2008 Jan 16. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk